OnKure Therapeutics, Inc. (OKUR) Capital expenditures 2020–2025
OnKure Therapeutics, Inc. (OKUR) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$46,000FY2025 · since FY2020: $24,000 → $46,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $46,000 | -11.5% |
| FY2024 | $52,000 | -78.9% |
| FY2023 | $246,000 | -28.9% |
| FY2022 | $346,000 | +74.7% |
| FY2021 | $198,000 | +725.0% |
| FY2020 | $24,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice